Pinealon dosage: reported doses and schedule
A peptide with unproven brain benefits and no established injection dose.
Also called: EDR, Glu-Asp-Arg, glutamyl-aspartyl-arginine.
Khavinson bioregulator peptides · Synthetic tripeptide studied for nerve-cell protection.
Typical reported dose: Two 0.1 mg capsules twice a day, by mouth
- 100 mcg twice daily for 2 weeks: 100 mcg twice daily for 14 days twice daily, by mouth. Studied in a trial. Studied in: Locomotive crew workers. (source)
- 15-day oral step up and down: Days 1–5: 100 mcg each morning, then Days 6–10: 100 mcg morning and evening, then Days 11–15: 100 mcg each morning once or twice daily, by day, by mouth. Studied in a trial. Studied in: 18 female judo athletes aged 16–22. (source)
- Review-described head-injury course: Two 0.1 mg capsules twice daily twice daily, by mouth. Clinician-published. Studied in: Adults with remote head injury in a clinician-authored review. (source)
- Reported 1 mg injection cycle: 1 mg daily for 20 days daily, under the skin. Reported by users, occasional report. Studied in: Adults reporting personal use online. (source)
- Reported rise from 1 to 2 mg: 1 mg daily, later increased to 2 mg daily, under the skin. Reported by users, occasional report. Studied in: Adults reporting personal use online. (source)
- Reported 5 mg cycle: 5 mg daily for 20 days daily, under the skin. Reported by users, rare report. Studied in: Adults reporting personal use online. (source)
These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.
Related to Pinealon
- Epitalon: A peptide with telomerase effects in cells, but no proof that people live longer.
- Thymalin: A calf thymus extract studied for immune problems, with uncertain safety and product identity.
- Thymogen: A Russian peptide used for immune problems, with negative cancer trials.
- Vesugen: An experimental blood-vessel peptide with unclear benefits and poorly defined safety.
- Cortagen: A four-amino-acid brain peptide backed mainly by animal work and unverified patent claims.
- DSIP: An experimental sleep peptide with small, mixed human studies and no FDA-approved dose.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, FDA · FDA · 2026
- July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee – FDA Briefing Document for Epitalon-Related Bulk Drug Substances (Epitalon (free base) and Epitalon acetate), FDA · 2026
- Medicines, European Medicines Agency · European Medicines Agency · 2026
- MHRA Products | Home, MHRA · MHRA · 2026
- Peptide products, Therapeutic Goods Administration · TGA · 2026
- Risks of buying peptide products online, Therapeutic Goods Administration · 2026
- Sepsis, NHS · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
- Using intramuscular injections in people on oral anticoagulants, NHS Specialist Pharmacy Service · NHS Specialist Pharmacy Service · 2023
- Preventing Unsafe Injection Practices, Centers for Disease Control and Prevention
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.